Tag: Lupin
Lupin & Birmingham City University honour graduates of master’s programme in...
This ground-breaking course is tailored to empower healthcare professionals with specialized skills and techniques to provide enhanced care for people living with diabetes
Lupin Digital Health introduces Digital Therapeutics Certificate for Cardiologists
This collaboration is crucial in ensuring top-notch care and enhancing outcomes, all from the convenience of patients' homes
Lupin Diagnostics expands presence in South India with New Regional Reference...
The newly launched laboratory enhances Lupin Diagnostics’ extensive network which now comprises of 36 laboratories and over 600 collection centers across India
Lupin and Amman Pharma sign exclusive licensing & supply agreement for...
Both Lupin and Amman Pharma are united in their mission to provide innovative, high-quality healthcare solutions to patients in the MENA region
Lupin announces resolution of US FDA warning letter for its Goa...
This is after the satisfactory evaluation of the corrective actions taken by the company in response to the Warning Letter that was issued on November 6, 2017
Lupin Diagnostics expands footprint, sets up Regional Reference Laboratory in Indore
The launch of best-in-class regional reference lab in Indore marks its expansion into Central India
BioVoice eMagazine November 2022 Issue 2 Volume 3
Click to Read: BioVoice News November 2022 Issue 2 Volume 3
The Cover Story in the current edition turns its spotlight on the genetically modified mustard. Its recent...
Lupin appoints Dr Shahin Fesharaki as Global CSO
Dr. Fesharaki will be responsible for Lupin’s global research and development efforts across branded, generics and specialty products
Lupin gets EIR from US FDA for its Ankleshwar manufacturing facility
The inspection of the facility was conducted from August 16-19, 2022
Lupin’s Rymti gets approval from Canadian regulator
Rymti is Lupin’s biosimilar etanercept approved for all indications of the reference product, Enbrel